The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $11.93 billion in 2025 to $13.11 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of injectable and inhalable therapies, increasing use of infusion-based treatments, growth in home healthcare adoption, availability of electronic drug delivery platforms.
The electronic drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $19.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for personalized drug delivery, rising adoption of digital health ecosystems, expansion of remote patient monitoring, growing focus on adherence-driven outcomes, increasing integration of ai-based dosing algorithms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising integration of connected and wearable delivery systems, growing use of precision dose control technologies, expansion of patient-centric self-administration devices, enhanced focus on therapy adherence monitoring.
The anticipated growth of the electronic drug delivery systems market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for more than a year and necessitating ongoing medical treatment, can benefit from electronic drug delivery systems that aid in regulating and monitoring drug doses. For example, in January 2023, the National Library of Medicine reported that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million by 2050. This upward trend in chronic diseases is poised to fuel the demand for electronic drug delivery systems.
Major companies in the electronic drug delivery systems market are increasingly focusing on innovative solutions, such as reusable electronic injector platforms, to improve dosing accuracy, patient adherence, and sustainability. Reusable electronic injector platforms are battery-powered, smart devices designed for multiple uses, delivering precise medication doses while tracking usage and supporting adherence. For example, in January 2025, Portal Instruments Inc., a US-based medical device company, launched the PRIME Nexus, a reusable electronic injector platform engineered to enhance the administration of injectable medications with improved precision, versatility, and sustainability. The system accommodates multiple drug container sizes, including 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and can handle high-viscosity formulations up to 600 cP. It provides programmable injection control and optional connectivity for adherence monitoring and data sharing with healthcare providers. Its reusable design supports sustainability by reducing medical waste and lowering overall injection costs.
In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to strengthen its central nervous system (CNS) drug delivery capabilities and expand its pipeline of targeted therapies. Alcyone Therapeutics Inc., a US-based healthcare technology company, specializes in developing advanced drug delivery platforms designed to enhance precision and efficacy in the treatment of neurological disorders.
Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.
North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electronic drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the electronic drug delivery systems market by increasing costs of imported sensors, microcontrollers, batteries, wireless modules, and precision pumps used in smart delivery devices. Pharmaceutical and medical device manufacturers in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device assembly. These tariffs are increasing production costs and device pricing. However, they are also encouraging domestic component sourcing, local assembly, and innovation in cost-efficient electronic drug delivery solutions.
The electronic drug delivery systems market research report is one of a series of new reports that provides electronic drug delivery systems market statistics, including electronic drug delivery systems industry global market size, regional shares, competitors with a electronic drug delivery systems market share, detailed electronic drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the electronic drug delivery systems industry. This electronic drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Electronic drug delivery systems encompass devices or formulations designed to facilitate the targeted delivery of a medical substance to a specific region while avoiding non-target cells and tissues. These systems ensure the controlled administration of drugs, allowing for easy monitoring of doses.
The primary categories of electronic drug delivery systems include electronic infusion pumps, electronic injection pens, electronic auto-injectors, electronic inhalers, electronic capsules, and other variants. Electronic infusion pumps are medical devices that regulate the controlled delivery of fluids into a patient's body. Deployed in healthcare settings such as hospitals and nursing homes, these pumps are instrumental in delivering fluids such as nutrients and medications. Essential components of electronic drug delivery systems comprise sensors, wireless communicators, antennas, micro-pumps, flow regulators, drug reservoirs, microcontrollers, and other elements, available in both battery-powered and rechargeable systems. These electronic drug delivery systems are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to the treatment of various conditions such as diabetes, cardiovascular disease, respiratory disorders, multiple sclerosis, and other ailments.
The electronic drug delivery systems market consists of sales of nasal sprays, eyedroppers, and intrauterine devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The electronic drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $19.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for personalized drug delivery, rising adoption of digital health ecosystems, expansion of remote patient monitoring, growing focus on adherence-driven outcomes, increasing integration of ai-based dosing algorithms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising integration of connected and wearable delivery systems, growing use of precision dose control technologies, expansion of patient-centric self-administration devices, enhanced focus on therapy adherence monitoring.
The anticipated growth of the electronic drug delivery systems market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for more than a year and necessitating ongoing medical treatment, can benefit from electronic drug delivery systems that aid in regulating and monitoring drug doses. For example, in January 2023, the National Library of Medicine reported that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million by 2050. This upward trend in chronic diseases is poised to fuel the demand for electronic drug delivery systems.
Major companies in the electronic drug delivery systems market are increasingly focusing on innovative solutions, such as reusable electronic injector platforms, to improve dosing accuracy, patient adherence, and sustainability. Reusable electronic injector platforms are battery-powered, smart devices designed for multiple uses, delivering precise medication doses while tracking usage and supporting adherence. For example, in January 2025, Portal Instruments Inc., a US-based medical device company, launched the PRIME Nexus, a reusable electronic injector platform engineered to enhance the administration of injectable medications with improved precision, versatility, and sustainability. The system accommodates multiple drug container sizes, including 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and can handle high-viscosity formulations up to 600 cP. It provides programmable injection control and optional connectivity for adherence monitoring and data sharing with healthcare providers. Its reusable design supports sustainability by reducing medical waste and lowering overall injection costs.
In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to strengthen its central nervous system (CNS) drug delivery capabilities and expand its pipeline of targeted therapies. Alcyone Therapeutics Inc., a US-based healthcare technology company, specializes in developing advanced drug delivery platforms designed to enhance precision and efficacy in the treatment of neurological disorders.
Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.
North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electronic drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the electronic drug delivery systems market by increasing costs of imported sensors, microcontrollers, batteries, wireless modules, and precision pumps used in smart delivery devices. Pharmaceutical and medical device manufacturers in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device assembly. These tariffs are increasing production costs and device pricing. However, they are also encouraging domestic component sourcing, local assembly, and innovation in cost-efficient electronic drug delivery solutions.
The electronic drug delivery systems market research report is one of a series of new reports that provides electronic drug delivery systems market statistics, including electronic drug delivery systems industry global market size, regional shares, competitors with a electronic drug delivery systems market share, detailed electronic drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the electronic drug delivery systems industry. This electronic drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Electronic drug delivery systems encompass devices or formulations designed to facilitate the targeted delivery of a medical substance to a specific region while avoiding non-target cells and tissues. These systems ensure the controlled administration of drugs, allowing for easy monitoring of doses.
The primary categories of electronic drug delivery systems include electronic infusion pumps, electronic injection pens, electronic auto-injectors, electronic inhalers, electronic capsules, and other variants. Electronic infusion pumps are medical devices that regulate the controlled delivery of fluids into a patient's body. Deployed in healthcare settings such as hospitals and nursing homes, these pumps are instrumental in delivering fluids such as nutrients and medications. Essential components of electronic drug delivery systems comprise sensors, wireless communicators, antennas, micro-pumps, flow regulators, drug reservoirs, microcontrollers, and other elements, available in both battery-powered and rechargeable systems. These electronic drug delivery systems are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to the treatment of various conditions such as diabetes, cardiovascular disease, respiratory disorders, multiple sclerosis, and other ailments.
The electronic drug delivery systems market consists of sales of nasal sprays, eyedroppers, and intrauterine devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Electronic Drug Delivery Systems Market Characteristics
3. Electronic Drug Delivery Systems Market Supply Chain Analysis
4. Global Electronic Drug Delivery Systems Market Trends and Strategies
5. Electronic Drug Delivery Systems Market Analysis of End Use Industries
7. Global Electronic Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Electronic Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market
9. Electronic Drug Delivery Systems Market Segmentation
10. Electronic Drug Delivery Systems Market Regional and Country Analysis
11. Asia-Pacific Electronic Drug Delivery Systems Market
12. China Electronic Drug Delivery Systems Market
13. India Electronic Drug Delivery Systems Market
14. Japan Electronic Drug Delivery Systems Market
15. Australia Electronic Drug Delivery Systems Market
16. Indonesia Electronic Drug Delivery Systems Market
17. South Korea Electronic Drug Delivery Systems Market
18. Taiwan Electronic Drug Delivery Systems Market
19. South East Asia Electronic Drug Delivery Systems Market
20. Western Europe Electronic Drug Delivery Systems Market
21. UK Electronic Drug Delivery Systems Market
22. Germany Electronic Drug Delivery Systems Market
23. France Electronic Drug Delivery Systems Market
24. Italy Electronic Drug Delivery Systems Market
25. Spain Electronic Drug Delivery Systems Market
26. Eastern Europe Electronic Drug Delivery Systems Market
27. Russia Electronic Drug Delivery Systems Market
28. North America Electronic Drug Delivery Systems Market
29. USA Electronic Drug Delivery Systems Market
30. Canada Electronic Drug Delivery Systems Market
31. South America Electronic Drug Delivery Systems Market
32. Brazil Electronic Drug Delivery Systems Market
33. Middle East Electronic Drug Delivery Systems Market
34. Africa Electronic Drug Delivery Systems Market
36. Electronic Drug Delivery Systems Market Competitive Landscape and Company Profiles
37. Electronic Drug Delivery Systems Market Other Major and Innovative Companies
40. Electronic Drug Delivery Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Electronic Drug Delivery Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses electronic drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for electronic drug delivery systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic drug delivery systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Electronic Infusion Pumps; Electronic Injection Pens; Electronic Auto-Injectors; Electronic Inhalers; Electronic Capsules2) By Component: Sensors; Wireless Communicator And Antennas; Micro Pumps And Flow Regulators; Drug Reservoir; Microcontroller; Other Components
3) By System Type: Battery-Powered Systems; Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
5) By Application: Diabetes; Cardiovascular Disease; Respiratory Disorders; Multiple Sclerosis; Other Applications
Subsegments:
1) By Electronic Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps2) By Electronic Injection Pens: Insulin Pens; Growth Hormone Pens; Other Injectable Medication Pens
3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors; Spring-Loaded Auto-Injectors
4) By Electronic Inhalers: Metered Dose Inhalers (MDI); Dry Powder Inhalers (DPI); Soft Mist Inhalers
5) By Electronic Capsules: Smart Capsules; Digital Capsules With Sensors
Companies Mentioned: Medtronic plc; Novo Nordisk A/S; Insulet Corporation; Tandem Diabetes Care Inc.; United Therapeutics Corporation; Sanofi S.A.; Abbott Laboratories; Roche Holding AG; Johnson & Johnson; Bayer AG; Antares Pharma Inc.; CeQur Corporation; BIOCORP; Adherium Limited; Amiko Digital Health Limited; FindAir Sp. z o.o.; HCmed Innovations Co. Ltd.; Insulet International Limited; Ypsomed Holding AG; Enable Injections Inc.; Eitan Medical Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Electronic Drug Delivery Systems market report include:- Medtronic plc
- Novo Nordisk A/S
- Insulet Corporation
- Tandem Diabetes Care Inc.
- United Therapeutics Corporation
- Sanofi S.A.
- Abbott Laboratories
- Roche Holding AG
- Johnson & Johnson
- Bayer AG
- Antares Pharma Inc.
- CeQur Corporation
- BIOCORP
- Adherium Limited
- Amiko Digital Health Limited
- FindAir Sp. z o.o.
- HCmed Innovations Co. Ltd.
- Insulet International Limited
- Ypsomed Holding AG
- Enable Injections Inc.
- Eitan Medical Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 13.11 Billion |
| Forecasted Market Value ( USD | $ 19.44 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
